Fundamental dimension Equity attribute | CAPTPeer $0.0615▲+925.00% Cap $2.01MP/E -0.0x QuantScore17/100 | AQMSLeader $1.47▼-1.34% Cap $5.24MP/E -0.2x QuantScore37/100 | CJMBPeer $0.574▲+10.17% Cap $2.74MP/E -0.3x QuantScore21/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
41/100 |
23/100 |
31/100 |
Valuation Multiples, PEG & DCF upside | 0/100 | 50/100 | 33/100 |
Health Piotroski, Altman Z, leverage & liquidity | 27/100 | 39/100 | 9/100 |
Growth Revenue / earnings growth & margins | 0/100 | 15/100 | 10/100 |
Sentiment Analyst ratings, targets & revisions | — | 60/100 | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -0.0x | -0.2x | -0.3x |
Forward P/E (next FY) | — | -0.1x | — |
EV / EBITDA (TTM) | -2.2x | -0.1x | -0.4x |
Price / Sales | 0.1x | — | 0.5x |
Price / Free Cash Flow | -0.2x | -0.5x | -0.7x |
PEG ratio | -0.00 | -0.00 | 0.01 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 4 / 9 | 2 / 9 | 3 / 9 |
Altman Z-Score | -11.99 (Distress) | -33.70 (Distress) | -10.16 (Distress) |
Total debt / equity | -0.50 | 0.05 | 3.14 |
Quick ratio | 0.1x | 2.3x | 1.2x |
Interest coverage | -5.4x | -433.1x | -1370.0x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -27.5% | — | -12.8% |
Net income growth YoY | -1168.3% | +7.8% | -247.3% |
Gross margin (TTM) | 13.9% | 0.0% | 39.9% |
Operating margin (FY) | -90.7% | — | -113.4% |
FCF margin (FY) | -72.9% | — | -90.2% |
5. Trailing price performancePrice change over period |
1M return | 0.0% | -41.0% | -73.8% |
3M return | -87.9% | -45.8% | -77.5% |
6M return | -91.3% | -68.5% | -44.3% |
Year to date | -82.1% | -69.4% | -48.3% |
1Y return | -87.3% | -84.1% | -86.0% |
3Y return | -99.3% | -99.1% | -85.7% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-12.21 -19949.3% premium | $7.75 +427.5% upside | $-1.12 -296.0% premium |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | 71% Buy29% Hold0% Sell | — |